Literature DB >> 27681173

Inhibitory Effect of TLR4 Gene Silencing on Intimal Hyperplasia of Vein Grafting.

Zhicheng Zhu1, Rihao Xu1, Xiaomei Zheng1, Tiance Wang1, Dan Li1, Yong Wang1, Kexiang Liu2.   

Abstract

PURPOSE: The present study aimed to explore the regulating effect of Toll-like receptor 4 (TLR4) on intimal hyperplasia in rat vein grafts.
METHODS: Rat models of external jugular vein carotid artery bypass grafting were established. Afterward, TLR4 small interfering RNA (siRNA) recombinant plasmids were constructed, which were transfected into rat vein graft bypass to study the effect of TLR4 silencing on intimal hyperplasia and to explore the underlying mechanisms. Real-time polymerase chain reaction and Western blot were used to detect the expression levels of TLR4 and inflammatory factors in TLR4 siRNA-transfected vein graft bypass. The intimal thickness was evaluated using hematoxylin-eosin staining.
RESULTS: Compared with the scramble siRNA group, the intimal thickness of vein grafting was decreased significantly, while the inflammatory factors including interleukin (IL) 1β, IL-6, and tumor necrosis factor α in grafted vein were dramatically downregulated in the TLR4 siRNA group.
CONCLUSION: These results showed that local silencing of TLR4 in the vein grafts could inhibit intimal hyperplasia by downregulating the expression of inflammatory factors in the vein grafts, suggesting that TLR4 can be used as a new target for therapy of vascular intimal hyperplasia.
© The Author(s) 2016.

Entities:  

Keywords:  zzm321990TLR4zzm321990; inflammatory factors; intimal hyperplasia; vein grafts

Mesh:

Substances:

Year:  2016        PMID: 27681173     DOI: 10.1177/1538574416670308

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  3 in total

1.  Moving Beyond the Assumed: Improving Fistula Success Rates.

Authors:  Jay B Wish; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2017-07-21       Impact factor: 10.121

2.  Tumor necrosis factor alpha-stimulated gene-6 (TSG-6) inhibits the inflammatory response by inhibiting the activation of P38 and JNK signaling pathway and decreases the restenosis of vein grafts in rats.

Authors:  Chengxin Zhang; Biao Zhang; Huiping Wang; Qianshan Tao; Shenglin Ge; Zhimin Zhai
Journal:  Heart Vessels       Date:  2017-10-03       Impact factor: 2.037

3.  Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242.

Authors:  Chuangyan Wu; Xiangchao Ding; Cheng Zhou; Ping Ye; Yuan Sun; Jie Wu; Anchen Zhang; Xiaofan Huang; Lingyun Ren; Ke Wang; Peng Deng; Zhang Yue; Jiuling Chen; Sihua Wang; Jiahong Xia
Journal:  Sci Rep       Date:  2017-11-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.